TADDEI, MARIA LETIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3430
EU - Europa 2776
AS - Asia 136
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6347
Nazione #
US - Stati Uniti d'America 3425
PL - Polonia 1394
IT - Italia 384
SE - Svezia 316
IE - Irlanda 309
UA - Ucraina 122
DE - Germania 92
FI - Finlandia 59
VN - Vietnam 47
CN - Cina 46
GB - Regno Unito 38
JO - Giordania 30
AT - Austria 17
BE - Belgio 16
FR - Francia 12
ES - Italia 11
TR - Turchia 9
CA - Canada 4
RU - Federazione Russa 4
SC - Seychelles 4
IN - India 2
NL - Olanda 2
EU - Europa 1
KR - Corea 1
MX - Messico 1
SG - Singapore 1
Totale 6347
Città #
Warsaw 1394
Fairfield 635
Dublin 309
Chandler 281
Ashburn 279
Cambridge 264
Woodbridge 262
Houston 229
Seattle 229
Wilmington 214
Jacksonville 185
Florence 144
Altamura 122
Lawrence 113
Ann Arbor 95
Princeton 79
Boston 53
Buffalo 46
Boardman 43
Dong Ket 41
Beijing 38
San Diego 34
Medford 32
Brussels 16
Falls Church 16
Norwalk 14
Auburn Hills 12
Barcelona 11
Vienna 11
Bremen 10
Dearborn 10
Izmir 9
Andover 8
Phoenix 8
Milan 7
Chieri 6
London 5
Redwood City 5
Frankfurt Am Main 4
Helsinki 4
Laurel 4
Toronto 4
Arezzo 3
Impruneta 3
Shanghai 3
Castelliri 2
Cedar Knolls 2
Lucca 2
Parma 2
Reggio Nell'emilia 2
Salerno 2
Verona 2
Arnsberg 1
Barletta 1
Bologna 1
Brentford 1
Brindisi 1
Calenzano 1
Castelnuovo 1
Chengdu 1
Groningen 1
Islington 1
Jiaxing 1
Kunming 1
Leawood 1
Los Angeles 1
Mexico City 1
Monsummano Terme 1
Naaldwijk 1
Naples 1
Napoli 1
Nottingham 1
Nürnberg 1
Odesa 1
Paris 1
Polesella 1
Portland 1
Prato 1
Redmond 1
Reggio Calabria 1
Rome 1
Saint Petersburg 1
San Mateo 1
Siena 1
Singapore 1
Trumbull 1
Xian 1
Totale 5343
Nome #
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. 238
Tyrosine-phosphorylated caveolin is a physiological substrate of the low M(r) protein-tyrosine Phosphatase 223
EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase 221
Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits 221
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. 219
Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells 214
The effects of CA IX catalysis products within tumor microenvironment 210
Globular adiponectin activates motility and regenerative traits of muscle satellite cells. 204
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread 147
miR-210-3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5-fluorouracil 131
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 118
Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy 116
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. 115
Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition 114
5-Fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like trait 113
Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1 109
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors 109
Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression. 107
Senescent stroma promotes prostate cancer progression: The role of miR-210 106
Inhibitory effect of full-length human endostatin on in vitro angiogenesis. 103
Down-regulation of platelet-derived growth factor receptor signaling during myogenesis. 99
LMW-PTP is a positive regulator of tumor onset and growth 97
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors. 97
Low Molecular Weight-Protein Tyrosine Phosphatase and Caveolin-1: Interaction and Isoenzyme-Dependent Regulation 94
EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style 89
Microenvironment and tumor cell plasticity: An easy way out. 86
INSULIN INHIBITS PLATELET-DERIVED GROWTH FACTOR-INDUCED CELL PROLIFERATION 86
Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species. 85
Low M(r) phosphotyrosine protein phosphatase interacts with the PDGF receptor directly via its catalytic site 85
Zoledronic Acid Inhibits the RhoA-mediated Amoeboid Motility of Prostate Cancer Cells. 85
Mitochondrial Oxidative Stress due to Complex I Dysfunction Promotes Fibroblast Activation and Melanoma Cell Invasiveness 84
LMW-PTP exerts a differential regulation on PDGF- and insulin-mediated signaling. 81
Characterization of a novel nucleolytic activity of acylphosphatases 81
Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells 79
Redox regulation of anoikis: reactive oxygen species as essential mediators of cell survival. 78
Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. 77
Low molecular weight protein-tyrosine phosphatase controls the rate and the strength of NIH-3T3 cells adhesion through its phosphorylation on tyrosine 131 or 132 77
The low M(r) protein-tyrosine phosphatase is involved in Rho-mediated cytoskeleton rearrangement after integrin and platelet-derived growth factor stimulation. 77
Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin 76
Lymphocyte function-associated antigen-1-mediated T cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity 75
Low molecular weight protein-tyrosine phosphatase is involved in growth inhibition during cell differentiation. 73
Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis 71
Acylphosphatase is involved in differentiation of K562 cells 70
Lactate in Sarcoma Microenvironment: Much More than just a Waste Product. 69
Anoikis: an emerging hallmark in health and diseases. 68
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 68
miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer. 65
EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells 64
SRC redox regulation: Again in the frontline. 62
RECIPROCAL METABOLIC REPROGRAMMING THROUGH LACTATE SHUTTLE COORDINATELY INFLUENCES TUMOR-STROMA INTERPLAY. 60
EphA2-mediated mesenchymal-amoeboid transition induced by endothelial progenitor cells enhances metastatic spread due to cancer-associated fibroblasts. 60
miR-205 Hinders the Malignant Interplay Between Prostate Cancer Cells and Associated Fibroblasts 55
Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment 55
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma 55
Low molecular weight protein-tyrosine phosphatase tyrosine phosphorylation by c-Src during platelet-derived growth factor-induced mitogenesis correlates with its subcellular targeting. 54
Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. 51
New perspectives in PDGF receptor downregulation: the main role of phosphotyrosine phosphatases 50
Targeted DNA oxidation by LSD1-SMAD2/3 primes TGF-β1/ EMT genes for activation or repression 48
Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. 47
Nuclear localization of TRK-A in liver cells. 47
Constitutive expression of interleukin-1beta (IL-1beta) in rat oligodendrocytes. 47
Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor. 45
Possible role of both isoforms of acylphosphatase in differentiation and apoptosis in k562 cells 44
Insight into the role of low molecular weight phosphotyrosine phosphatase (LMW-PTP) on platelet-derived growth factor receptor (PDGF-r) signaling. LMW-PTP controls PDGF-r kinase activity through TYR-857 dephosphorylation 44
Role of tyrosine phosphorylation in modulating cancer cell metabolism 39
Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyrosine phosphatase. 33
The low mr phosphotyrosine protein phosphatase behaves differently when phosphorylated at tyr131 or tyr132 by src kinase. 32
The miR-27a/FOXJ3 Axis Dysregulates Mitochondrial Homeostasis in Colorectal Cancer Cells 32
Claisened hexafluoro inhibits metastatic spreading of amoeboid melanoma cells 31
SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis 27
Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids 25
Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies 14
Therapy-induced stromal senescence promoting aggressiveness of prostate and ovarian cancer 13
Transcriptomic analysis of colorectal cancer cells treated with oil production waste products (OPWPs) reveals enrichment of pathways of mitochondrial functionality 10
Mitochondrial oxidative stress due to complex I dysfunction promotes fibroblast activation and melanoma cell invasiveness 6
Metabolic reprogramming in cholangiocarcinoma 6
Chemoenzymatic Synthesis of Glycopeptides to Explore the Role of Mucin 1 Glycosylation in Cell Adhesion 5
Totale 6471
Categoria #
all - tutte 11319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201841 0000 00 00 00041
2018/2019774 20173518 7117 2918 38107214190
2019/20201575 10412355126 157181 156221 16211614727
2020/20211327 8810374181 66147 76102 1112255995
2021/2022628 25636621 2526 3534 2532121155
2022/20231513 12431988102 106255 21895 14810480
Totale 6471